17 Firmen mit Ergebnissen für "considerable"

Somagenetix

https://www.wysszurich.ch/projects/somagenetix  

8952 Schlieren, Wagistrasse 23

Gene therapy solutions for patients with severe inherited diseases.

Somagenetix

Wagistrasse 23

8952 Schlieren

599 Ergebnisse für "considerable" unter Somagenetix

Examination of food chain-derived L. monocytogenes of different ser...

... chain-derived L. monocytogenes of different serotypes reveals considerable diversity among inlA ... Examination of food chain-derived L. monocytogenes of different serotypes reveals considerable ... Examination of food chain-derived L. monocytogenes of different serotypes reveals considerable ... Examination of food chain-derived L. monocytogenes of different serotypes reveals considerable ...

Data & Results – Page 3 – URPP Language and Space – Blog

... considerable challenge due to the fact that it is mostly a spoken variety and that it is subject to ... considerable regional variation. Our paper presents the ArchiMob […] December 10, 2018 ... fact, automatic processing of Swiss German is still a considerable challenge due to the fact that it is ... mostly a spoken variety and that it is subject to considerable regional variation. Our paper presents the ...

Mehr Ergebnisse

ETH Entrepreneurship

https://ethz.ch/en/industry/entrepreneurship.html  

8952 Schlieren, Wagistrasse 18


 entrepreneurship@ethz.ch

Excellence in entrepreneurship at ETH Zurich is driven by world-​class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions. 

ETH Entrepreneurship

Wagistrasse 18

8952 Schlieren

524 Ergebnisse für "considerable" unter ETH Entrepreneurship

2016 – Department of Environmental Systems Science | ETH Zurich

... already caused considerable economic damage in Switzerland. In a joint project, ETH Zurich and Agroscope ... -wing drosophila – is a vinegar fly that has already caused considerable economic damage in Switzerland ...

March 26, 2015: Petascale Computing and High-Precision Arithmetic: ...

... and engineers.  However, there is considerable danger here also, for example from greatly magnified ... shown where such precision is not only useful, but in fact mandatory.  Other problems of considerable ... power to scientists and engineers.  However, there is considerable danger here also, for example from ... considerable interest require much more precision — hundreds or even thousands of digits.  Providing efficient ...

Mehr Ergebnisse

University of Zurich

https://www.campus-schlieren.uzh.ch/en.html  

8952 Schlieren, Wagistrasse 12

The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.

University of Zurich

Wagistrasse 12

8952 Schlieren

428 Ergebnisse für "considerable" unter University of Zurich

UZH - Department of Geography - 1894–2019: 125 years of internation...

...  World Glacier Monitoring Service (WGMS), located at the Department of Geography, attracted considerable ... considerable media attention. We are well aware that the Earth's glaciers have declined massively in recent ...

INI Institute of Neuroinformatics Acoustic source separation by mea...

... of speech signals into the contributing sources, is a challenging theoretical problem of considerable ... the contributing sources, is a challenging theoretical problem of considerable practical significance ...

Mehr Ergebnisse

Kuros Biosciences AG

https://kurosbio.com/  

8952 Schlieren, Wagistrasse 25

 +41 (0)44 733 4747

Our focus is on revolutionizing the field of orthobiologics by developing bone grafts that deliver both targeted and controlled bone healing.

Kuros Biosciences AG

Wagistrasse 25

8952 Schlieren

4 Ergebnisse für "considerable" unter Kuros Biosciences AG

Dr. Philippe Saudan - Kuros Biosciences

... considerable experience in R&D and international project management of multidisciplinary programs. Dr. Saudan ... industry and held different management roles in research and development. Dr. Saudan has considerable ...

Kuros BioSciences - Executive Committee

... pharmaceutical industry and held different management roles in R&D. Dr. Saudan has considerable experience in R&D ... different management roles in R&D. Dr. Saudan has considerable experience in R&D and international project ... roles in R&D. Dr. Saudan has considerable experience in R&D and international project management of ... roles in R&D. Dr. Saudan has considerable experience in R&D and international project management of ...

Mehr Ergebnisse

Roche Glycart AG

https://www.roche.ch/en/sites/schlieren  

8952 Schlieren, Wagistrasse 10

 +41 43 215 10 00

The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.

Roche Glycart AG

Wagistrasse 10

8952 Schlieren

54 Ergebnisse für "considerable" unter Roche Glycart AG

cobas® Liat® System | Lab-quality results in a tube

... respiratory infections poses a considerable challenge to the differential diagnosis of pathogens. What impact ... presentation of respiratory infections poses a considerable challenge to the differential diagnosis of ... respiratory infections poses a considerable challenge to the differential diagnosis of pathogens. What impact ... considerable challenge to the differential diagnosis of pathogens. What impact can a timely and accurate ...

Available assays for the cobas® Liat® PCR System

... The non-specific clinical presentation of respiratory infections poses a considerable challenge to the ... poses a considerable challenge to the differential diagnosis of pathogens. What impact can a timely and ...

Mehr Ergebnisse

Virometix AG

http://virometix.com  

8952 Schlieren, Wagistrasse 14

 +41 (0)43 433 86 60
 info@virometix.com

Virometix AG is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases.

Virometix AG

Wagistrasse 14

8952 Schlieren

9 Ergebnisse für "considerable" unter Virometix AG

... clinic with V-306. Considerable efforts over the last few years to develop this innovative synthetic ... treatment of infections and cancer. In an increasingly global world, there is a considerable medical need ... clinic with V-306. Considerable efforts over the last few years to develop this innovative synthetic ... treatment of infections and cancer. In an increasingly global world, there is a considerable medical need ...

Microsoft Word - Virometix_Press Release-V-306 Phase I Trial-1st Co...

... treatment of infections and cancer. In an increasingly global world, there is a considerable medical need ... treatment of infections and cancer. In an increasingly global world, there is a considerable medical need ...

Mehr Ergebnisse

Bio-Technopark Schlieren-Zürich

http://www.bio-technopark.ch/  

8952 Schlieren, Wagistrasse 23

 +41 76 336 99 44
 mario.jenni@bio-technopark.ch

The Bio-Technopark offers professional support for life science start-ups in the setting up and expansion of business activities and promotes interaction between start-ups, academia and industry. A nationally and internationally respected science park has grown up at Schlieren. Through stringent selection, coaching and support, more than 30 successful start-up companies with 750 employees are located here. Eight have been acquired by large corporates, but are still active in the park. Together with 20 institutes and clinics from the University and University Hospital Zurich, an innovative mix of very young and well-established companies and academic research groups has emerged.

Bio-Technopark Schlieren-Zürich

Wagistrasse 23

8952 Schlieren

3 Ergebnisse für "considerable" unter Bio-Technopark Schlieren-Zürich

Bio-Technopark Schlieren-Zurich › BIO-TECHNOPARK® Schlieren-Zürich

... . Considerable financing rounds, the initial public offering of Molecular Partners, and successful product ... . Considerable financing rounds, the initial public offering of Molecular Partners, and successful product ...

Allergan, an AbbVie Company, and Molecular Partners Receive Complet...

... dramatically in the coming decades, posing a considerable challenge to healthcare systems. Through building a ... dramatically in the coming decades, posing a considerable challenge to healthcare systems. Through building a ...

Mehr Ergebnisse

University Hospital Zurich​, Research and Education Office

https://www.usz.ch/forschung/Seiten/default.aspx  

8091 Zürich, Rämistrasse 100

The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.

University Hospital Zurich​, Research and Education Office

Rämistrasse 100

8091 Zürich

35 Ergebnisse für "considerable" unter University Hospital Zurich​, Research and Education Office

Slide A III 23

... fibrosis and presence of a chronic inflammatory infiltrate. Fibrosis shows considerable variation and is in ... fibrosis and presence of a chronic inflammatory infiltrate. Fibrosis shows considerable variation and is in ...

Slide A IV 18

... inflammation). - The submucosa exhibits considerable fibrosis. The transmural inflammation with formation of ... submucosa exhibits considerable fibrosis. The transmural inflammation with formation of lymphoid aggregates ...

Mehr Ergebnisse

Molecular Partners AG

http://www.molecularpartners.com  

8952 Schlieren, Wagistrasse 14

 +41 44 755 77 00

Molecular Partners AG is a clinical-stage biopharmaceutical company, located in Schlieren, Switzerland, that is developing a new class of therapies known as DARPin® therapies.

Molecular Partners AG

Wagistrasse 14

8952 Schlieren

4 Ergebnisse für "considerable" unter Molecular Partners AG

Molecular Partners appoints Göran Ando as independent non executive...

... -executive member of the board of directors. Dr Ando brings considerable experience to the board of Molecular ... independent non-executive member of the board of directors. Dr Ando brings considerable experience to the ...

Appointment of Steven Holtzman as independent board member - Molecu...

... our decisions as the company further matures.” Mr. Holtzman brings considerable experience to the ... further matures.” Mr. Holtzman brings considerable experience to the board of Molecular Partners. He is ...

Mehr Ergebnisse

CSL Vifor

https://www.csl.com/we-are-csl/our-businesses-and-products/csl-vifor  

8952 Schlieren, Zürcherstrasse 39D

 +41 58 851 80 00

Pioneer in iron-based therapies, CSL Vifor is a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, when pharmacist Caspar Friedrich Hausmann opened a pharmacy in St. Gallen, Switzerland. Since then, we have proven our ability to identify and serve therapeutic areas and patients with significant unmet medical need. Building on our heritage and expertise in iron deficiency therapy, and together with our joint company Vifor Fresenius Medical Care Renal Pharma, today we have a strong and rapidly growing presence in nephrology, and we are committed to launching the next generation of therapies to truly address the full spectrum of kidney disease.

CSL Vifor

Zürcherstrasse 39D

8952 Schlieren

4 Ergebnisse für "considerable" unter CSL Vifor

Tax Transparency Statement June 2020.pdf

... -grounded, and considerable in their persuasiveness, and at least “Reasonably Arguable”; • Only enter ... -grounded, and considerable in their persuasiveness, and at least “Reasonably Arguable”; • Only enter ...

Microsoft Word - Tax Transparency Statement June 2018

... cogent, well-grounded, and considerable in their persuasiveness;  Only enter arrangements and adopt ... cogent, well-grounded, and considerable in their persuasiveness;  Only enter arrangements and adopt ...

Mehr Ergebnisse

Mehr Firmen

Nach oben